The maker of Budweiser is partnering with medical cannabis company Tilray in a $100 million deal to research cannabis-infused drinks for the Canadian market....
The move alters the language of a major drug law that had previously remained unchanged for half a century and loosely defined hemp alongside marijuana as a controlled substance. The new bill exempts hemp from that law and defines it as an agricultural product. That...
Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today provides the following update on its Latin American operations, including its previously completed LATAM acquisition of LATAM Holdings Inc....
Medical marijuana will still be tightly restricted, but the law’s approval by the central government is seen as a breakthrough in a country many believed would be last – not among the first – to approve any use of cannabis, even if it is just...
Attorney General Jeff Sessions has resigned at the request of President Trump. The move follows months of Mr. Trump expressing his displeasure with Mr. Sessions in critical tweets....
FSD Pharma Inc. ("FSD Pharma") (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) announced today that its strategic R&D partner, SciCann Therapeutics Inc. ("SciCann") received a positive International Search Authority (ISA) report from the Patent Cooperation Treaty (PCT) for its SCN-001 cannabidiol (CBD) combination therapy, the basis...
True Leaf Medicine International Ltd. (CSE: MJ) (OTCQB: TRLFF) (FSE: TLA) today announced it has surpassed 2,800 retail locations across North America and Europe and has launched e-commerce direct-to-consumer stores in three major European markets. ...
